349 related articles for article (PubMed ID: 28036132)
1. Diagnostic accuracy of salivary and serum-free light chain assays in primary Sjögren's syndrome: a pilot study.
Sandhya P; Christudoss P; Kabeerdoss J; Mandal SK; Aithala R; Mahasampath G; Job V; Danda D
Int J Rheum Dis; 2017 Jun; 20(6):760-766. PubMed ID: 28036132
[TBL] [Abstract][Full Text] [Related]
2. Salivary free light chains and salivary immunoglobulins as potential non-invasive biomarkers in primary Sjögren's syndrome.
Sandhya P; Kabeerdoss J; Christudoss P; Arulraj R; Mandal SK; Janardana R; Chebbi PP; Ganesan MP; Mahasampath G; Danda D
Int J Rheum Dis; 2022 Jan; 25(1):61-69. PubMed ID: 34791797
[TBL] [Abstract][Full Text] [Related]
3. Could the complement component C4 or its fragment C4d be a marker of the more severe conditions in patients with primary Sjögren's syndrome?
Sudzius G; Mieliauskaite D; Siaurys A; Viliene R; Butrimiene I; Characiejus D; Dumalakiene I
Rheumatol Int; 2014 Feb; 34(2):235-41. PubMed ID: 24166212
[TBL] [Abstract][Full Text] [Related]
4. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
[TBL] [Abstract][Full Text] [Related]
5. CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren's syndrome.
Mandal SK; Sandhya P; Kabeerdoss J; Ramya J; Mahasampath G; Danda D
Rheumatol Int; 2018 May; 38(5):831-836. PubMed ID: 29541901
[TBL] [Abstract][Full Text] [Related]
6. Serum immunoglobulin free light chains are sensitive biomarkers for monitoring disease activity and treatment response in primary Sjögren's syndrome.
Verstappen GM; Moerman RV; van Nimwegen JF; van Ginkel MS; Bijzet J; Mossel E; Vissink A; Hazenberg BPC; Arends S; Kroese FGM; Bootsma H
Rheumatology (Oxford); 2018 Oct; 57(10):1812-1821. PubMed ID: 29982712
[TBL] [Abstract][Full Text] [Related]
7. Soluble siglec-5 is a novel salivary biomarker for primary Sjogren's syndrome.
Lee J; Lee J; Baek S; Koh JH; Kim JW; Kim SY; Chung SH; Choi SS; Cho ML; Kwok SK; Ju JH; Park SH
J Autoimmun; 2019 Jun; 100():114-119. PubMed ID: 30922727
[TBL] [Abstract][Full Text] [Related]
8. Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.
Moutsopoulos HM; Tzioufas AG; Bai MK; Papadopoulos NM; Papadimitriou CS
Ann Rheum Dis; 1990 Nov; 49(11):929-31. PubMed ID: 2124096
[TBL] [Abstract][Full Text] [Related]
9. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
10. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren's syndrome adults from a defined population.
Akiyama M; Sasaki T; Kaneko Y; Yasuoka H; Suzuki K; Yamaoka K; Takeuchi T
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):157-164. PubMed ID: 29465360
[TBL] [Abstract][Full Text] [Related]
11. Younger patients with primary Sjögren's syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies.
Jayakanthan K; Ramya J; Mandal SK; Sandhya P; Gowri M; Danda D
Clin Rheumatol; 2016 Mar; 35(3):657-62. PubMed ID: 26809799
[TBL] [Abstract][Full Text] [Related]
12. Investigation of three potential autoantibodies in Sjogren's syndrome and associated MALT lymphoma.
Cui L; Elzakra N; Xu S; Xiao GG; Yang Y; Hu S
Oncotarget; 2017 May; 8(18):30039-30049. PubMed ID: 28404907
[TBL] [Abstract][Full Text] [Related]
13. Expression of NGAL-specific cells and mRNA levels correlate with inflammation in the salivary gland, and its overexpression in the saliva, of patients with primary Sjögren's syndrome.
Aqrawi LA; Jensen JL; Fromreide S; Galtung HK; Skarstein K
Autoimmunity; 2020 Sep; 53(6):333-343. PubMed ID: 32686529
[TBL] [Abstract][Full Text] [Related]
14. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.
Gottenberg JE; Seror R; Miceli-Richard C; Benessiano J; Devauchelle-Pensec V; Dieude P; Dubost JJ; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Le Guern V; Morel J; Perdriger A; Puéchal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Nocturne G; Ravaud P; Mariette X
PLoS One; 2013; 8(5):e59868. PubMed ID: 23717383
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the diagnostic value of four scoring systems in primary sjögren's syndrome patients.
Qi X; Sun C; Tian Y; Han Y; Peng C; Jin H; Gao L; Guo H
Immunol Lett; 2017 Aug; 188():9-12. PubMed ID: 28528128
[TBL] [Abstract][Full Text] [Related]
16. Ultrasonographic evaluation of major salivary glands in primary Sjögren's syndrome: comparison of two scoring systems.
Zhang X; Zhang S; He J; Hu F; Liu H; Li J; Zhu J; Li Z
Rheumatology (Oxford); 2015 Sep; 54(9):1680-7. PubMed ID: 25936787
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands.
Alunno A; Caneparo V; Carubbi F; Bistoni O; Caterbi S; Gariglio M; Bartoloni E; Landolfo S; Gerli R
Reumatismo; 2015 Dec; 67(3):85-90. PubMed ID: 26876186
[TBL] [Abstract][Full Text] [Related]
18. Role of salivary anti-SSA/B antibodies for diagnosing primary Sjögren's syndrome.
Wei P; Li C; Qiang L; He J; Li Z; Hua H
Med Oral Patol Oral Cir Bucal; 2015 Mar; 20(2):e156-60. PubMed ID: 25475778
[TBL] [Abstract][Full Text] [Related]
19. Chemokine saliva levels in patients with primary Sjögren's syndrome, associated Sjögren's syndrome, pre-clinical Sjögren's syndrome and systemic autoimmune diseases.
Hernández-Molina G; Michel-Peregrina M; Hernández-Ramírez DF; Sánchez-Guerrero J; Llorente L
Rheumatology (Oxford); 2011 Jul; 50(7):1288-92. PubMed ID: 21330342
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes.
Baldini C; Giusti L; Ciregia F; Da Valle Y; Giacomelli C; Donadio E; Sernissi F; Bazzichi L; Giannaccini G; Bombardieri S; Lucacchini A
Arthritis Res Ther; 2011; 13(6):R194. PubMed ID: 22117835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]